FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149666119> ?p ?o ?g. }

• W2149666119 endingPage "451" @default.
• W2149666119 startingPage "443" @default.
• W2149666119 abstract "Tumor necrosis factor-α (TNF-α) has been implicated in the pathogenesis of asthma, and neutralization of TNF-α is an effective therapy for inflammatory diseases. The present study tested the idea that a TNF-α antibody, infliximab, may be useful in the management of asthma. E3 rats were immunized with ovalbumin (OVA)/alum and received infliximab intra-peritoneally. Two weeks later, OVA-PBS was instilled intranasally daily for 7 days. Bronchoalveolar lavage fluids (BALFs), serum and lung homogenates were collected for analysis of cells and inflammatory mediators. Contractile responses of lobar-bronchus segments to agonists were functionally tested. Pulmonary tissues were investigated using histological examination. The results showed that the sensitized 'model E3 rats' exhibited an increase in the total amount of inflammatory cells, primarily eosinophils, in BALF and pulmonary tissue, as well as epithelial damage. Serum levels of IgE increased and so did the levels of nitric oxide, inducible nitric oxide synthase, TNF-α and IL-4, IL-5 and IL-13 in lung homogenate and serum. Furthermore, the contractile responses in bronchi induced by endothelin-1, sarafotoxin 6c and bradykinin increased and isoprenaline-induced relaxations decreased. All these changes induced by the sensitization procedure were reduced by the infliximab treatment. The results suggest that infliximab prevents the development of local airway inflammation and antagonizes changes of the bronchial smooth muscle receptor phenotype, thereby blocking the development of airway smooth muscle hyperreactivity of asthmatic rats." @default.
• W2149666119 created "2016-06-24" @default.
• W2149666119 creator A5011245802 @default.
• W2149666119 creator A5014783289 @default.
• W2149666119 creator A5035165090 @default.
• W2149666119 creator A5035599338 @default.
• W2149666119 creator A5047516585 @default.
• W2149666119 date "2011-06-15" @default.
• W2149666119 modified "2023-10-02" @default.
• W2149666119 title "Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats" @default.
• W2149666119 cites W1574785846 @default.
• W2149666119 cites W1792317929 @default.
• W2149666119 cites W1859203717 @default.
• W2149666119 cites W1964187430 @default.
• W2149666119 cites W1964924481 @default.
• W2149666119 cites W1968295892 @default.
• W2149666119 cites W2025111901 @default.
• W2149666119 cites W2027187981 @default.
• W2149666119 cites W2028432085 @default.
• W2149666119 cites W2032054363 @default.
• W2149666119 cites W2038053724 @default.
• W2149666119 cites W2038425317 @default.
• W2149666119 cites W2048964332 @default.
• W2149666119 cites W2053890950 @default.
• W2149666119 cites W2063907751 @default.
• W2149666119 cites W2065514618 @default.
• W2149666119 cites W2069831315 @default.
• W2149666119 cites W2071175229 @default.
• W2149666119 cites W2071266539 @default.
• W2149666119 cites W2071706088 @default.
• W2149666119 cites W2079460465 @default.
• W2149666119 cites W2084433985 @default.
• W2149666119 cites W2097750657 @default.
• W2149666119 cites W2101524187 @default.
• W2149666119 cites W2106311864 @default.
• W2149666119 cites W2109749945 @default.
• W2149666119 cites W2121464855 @default.
• W2149666119 cites W2124657474 @default.
• W2149666119 cites W2134221879 @default.
• W2149666119 cites W2140847787 @default.
• W2149666119 cites W2144831051 @default.
• W2149666119 cites W2145611796 @default.
• W2149666119 cites W2155612793 @default.
• W2149666119 cites W2155675334 @default.
• W2149666119 cites W2172037552 @default.
• W2149666119 doi "https://doi.org/10.1093/intimm/dxr032" @default.
• W2149666119 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21677048" @default.
• W2149666119 hasPublicationYear "2011" @default.
• W2149666119 type Work @default.
• W2149666119 sameAs 2149666119 @default.
• W2149666119 citedByCount "22" @default.
• W2149666119 countsByYear W21496661192012 @default.
• W2149666119 countsByYear W21496661192013 @default.
• W2149666119 countsByYear W21496661192014 @default.
• W2149666119 countsByYear W21496661192015 @default.
• W2149666119 countsByYear W21496661192016 @default.
• W2149666119 countsByYear W21496661192017 @default.
• W2149666119 countsByYear W21496661192019 @default.
• W2149666119 countsByYear W21496661192020 @default.
• W2149666119 countsByYear W21496661192021 @default.
• W2149666119 countsByYear W21496661192022 @default.
• W2149666119 crossrefType "journal-article" @default.
• W2149666119 hasAuthorship W2149666119A5011245802 @default.
• W2149666119 hasAuthorship W2149666119A5014783289 @default.
• W2149666119 hasAuthorship W2149666119A5035165090 @default.
• W2149666119 hasAuthorship W2149666119A5035599338 @default.
• W2149666119 hasAuthorship W2149666119A5047516585 @default.
• W2149666119 hasBestOaLocation W21496661191 @default.
• W2149666119 hasConcept C126322002 @default.
• W2149666119 hasConcept C134018914 @default.
• W2149666119 hasConcept C141105273 @default.
• W2149666119 hasConcept C159654299 @default.
• W2149666119 hasConcept C17991360 @default.
• W2149666119 hasConcept C203014093 @default.
• W2149666119 hasConcept C2776178081 @default.
• W2149666119 hasConcept C2776914184 @default.
• W2149666119 hasConcept C2776946954 @default.
• W2149666119 hasConcept C2777138892 @default.
• W2149666119 hasConcept C2777714996 @default.
• W2149666119 hasConcept C2777961210 @default.
• W2149666119 hasConcept C2780314925 @default.
• W2149666119 hasConcept C519581460 @default.
• W2149666119 hasConcept C71924100 @default.
• W2149666119 hasConcept C8891405 @default.
• W2149666119 hasConceptScore W2149666119C126322002 @default.
• W2149666119 hasConceptScore W2149666119C134018914 @default.
• W2149666119 hasConceptScore W2149666119C141105273 @default.
• W2149666119 hasConceptScore W2149666119C159654299 @default.
• W2149666119 hasConceptScore W2149666119C17991360 @default.
• W2149666119 hasConceptScore W2149666119C203014093 @default.
• W2149666119 hasConceptScore W2149666119C2776178081 @default.
• W2149666119 hasConceptScore W2149666119C2776914184 @default.
• W2149666119 hasConceptScore W2149666119C2776946954 @default.
• W2149666119 hasConceptScore W2149666119C2777138892 @default.
• W2149666119 hasConceptScore W2149666119C2777714996 @default.
• W2149666119 hasConceptScore W2149666119C2777961210 @default.
• W2149666119 hasConceptScore W2149666119C2780314925 @default.
• W2149666119 hasConceptScore W2149666119C519581460 @default.

• next